CVE-2021-33223
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid...
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid and role parameters in the out.UsrMgr.php file.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid and role parameters in the out.UsrMgr.php file.
- Record
CVE-2021-33223- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-639
- Updated
- 2026-11-02
CVE List No score
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid and role parameters in the out.UsrMgr.php file.
- Record
CVE-2021-33223- Updated
- 2026-11-02
EUVDEUVD-2021-19935 No score
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid and role parameters in the out.UsrMgr.php file.
- Record
EUVD-2021-19935- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-5r42-grwv-4wqj
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid...
An issue discovered in SeedDMS 6.0.15 allows an attacker to escalate privileges via the userid and role parameters in the out.UsrMgr.php file.
- Record
GHSA-5r42-grwv-4wqj- CVSS 3.1
- 8.8 High
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-639
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2021-33223 is a high vulnerability (CVSS 8.8) in Seeddms, published June 7, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.80%, the 56th percentile. No source names a fixed version.